BR100 Decreased By (-0.26%)
BR30 Decreased By (-0.53%)
KSE100 Decreased By (-0.29%)
KSE30 Decreased By (-0.22%)
AGHA 6.56 Decreased By ▼ -0.11 (-1.65%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 55.89 Decreased By ▼ -0.28 (-0.5%)
BOP 30.05 Decreased By ▼ -0.07 (-0.23%)
CNERGY 12.75 Decreased By ▼ -0.23 (-1.77%)
CSIL 5.21 Decreased By ▼ -0.10 (-1.88%)
FCCL 51.00 Decreased By ▼ -0.65 (-1.26%)
FFL 14.43 Decreased By ▼ -0.06 (-0.41%)
FNEL 1.22 Increased By ▲ 0.01 (0.83%)
KEL 5.97 Decreased By ▼ -0.09 (-1.49%)
KOSM 5.58 Decreased By ▼ -0.26 (-4.45%)
LOTCHEM 26.15 Decreased By ▼ -0.02 (-0.08%)
MLCF 90.33 Decreased By ▼ -0.90 (-0.99%)
NBP 161.45 Decreased By ▼ -2.74 (-1.67%)
NCPL 52.55 Decreased By ▼ -0.63 (-1.18%)
NPL 57.98 Decreased By ▼ -1.14 (-1.93%)
OGDC 315.40 Increased By ▲ 2.01 (0.64%)
PACE 9.70 Decreased By ▼ -0.07 (-0.72%)
PAEL 34.73 Decreased By ▼ -0.51 (-1.45%)
PIBTL 14.23 Decreased By ▼ -0.48 (-3.26%)
PPL 221.00 Decreased By ▼ -0.36 (-0.16%)
PRL 90.89 Decreased By ▼ -0.33 (-0.36%)
PTC 59.25 Increased By ▲ 0.06 (0.1%)
SSGC 23.39 Increased By ▲ 0.09 (0.39%)
TBL 8.65 Decreased By ▼ -0.10 (-1.14%)
TELE 7.40 Decreased By ▼ -0.21 (-2.76%)
TPL 21.00 Decreased By ▼ -1.03 (-4.68%)
TPLP 12.02 Decreased By ▼ -0.54 (-4.3%)
TREET 21.33 Decreased By ▼ -0.40 (-1.84%)
TRG 54.35 Decreased By ▼ -1.44 (-2.58%)
Pakistan

Novartis donates RS41.25mn to PRCS for the fight against COVID-19 pandemic

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas m
Published Updated
  • Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Novartis donated PKR 41.25 Million to Pakistan Red Crescent Society (PRCS), one of the largest humanitarian organizations in the country to support in efforts against COVID-19.

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Dr. Imran Rasheed, Chief Executive Officer, Novartis Pharma Pakistan, said, “Novartis Pakistan feels proud to stand with our Healthcare Professionals at their hour of need and hope to mitigate and contain this deadly infection as soon as humanly possible. Novartis has always remained on the forefront when it comes to Corporate Social Responsibility.

In Pakistan, we have ongoing projects in collaboration with government, NGOs and other partners working actively for the benefits of patients. We have the biggest Oncology Access program in Pakistan, providing cancer medicines free of cost, worth billions of rupees. During this challenging time of COVID-19 Pandemic, with this donation, Novartis contributing back to the society is core to our strategy and one of the pillars of Novartis vision”.

Comments

Comments are closed for this article.